CYB561D1 Antibody

Definition and Function

The CYB561D1 antibody is a research-grade immunological reagent designed to target the cytochrome b-561 domain-containing protein 1 (CYB561D1), a multi-pass transmembrane protein. This protein is hypothesized to function as a transmembrane reductase, utilizing ascorbate as an electron donor to reduce monodehydro-L-ascorbate radicals and iron cations (Fe³⁺) in cellular compartments . Its expression is critical in maintaining redox balance and antioxidant defense mechanisms, particularly in tissues requiring high oxidative stress tolerance.

Applications in Research

The CYB561D1 antibody is primarily employed in immunohistochemistry (IHC) and Western blotting to study protein localization and expression levels in human tissues . It has been validated for use in:

• Cancer research: Investigating CYB561D1’s role in tumor progression and oxidative stress adaptation .

• Neurological studies: Exploring its involvement in cellular antioxidant networks .

• Basic biochemistry: Mapping protein-protein interactions and subcellular localization .

Mechanistic Insights

The antibody’s specificity is derived from its affinity-purified design, targeting the C-terminal region of CYB561D1. This ensures minimal cross-reactivity with homologous proteins, a critical factor in high-sensitivity assays . Its utility in T-cell assays highlights its role in antigen-specific immune responses, where it can stimulate T-cell activation or expansion .

Research Findings

Recent studies leveraging the CYB561D1 antibody have:

• Linked CYB561D1 to oxidative stress resilience in cancer cells, suggesting its potential as a therapeutic target .

• Mapped subcellular localization to membrane-bound compartments, aligning with its proposed role in electron transport .

• Highlighted its expression variability across tissues, with elevated levels observed in kidney and liver samples .

Future Directions

Emerging research aims to:

• Explore CYB561D1’s interaction network, leveraging co-immunoprecipitation assays with the antibody .

• Investigate its role in neurodegenerative diseases, where oxidative damage is a key pathological feature .

• Develop therapeutic antibodies targeting CYB561D1 for cancer treatment, based on its pro-survival functions .

This antibody serves as a foundational tool in advancing our understanding of CYB561D1’s biological and pathological roles, bridging gaps between molecular mechanisms and clinical applications.